$2.64
-0.03-1.12%
Pre-Market: 5:10 AM EDT
15 minutes delayed
Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.35 | $-0.35 | 0.00 % |
Mar 2024 | 2024-05-13 | $-0.38 | $-0.41 | 7.32 % |
Dec 2023 | 2024-03-14 | $-0.43 | $-0.45 | 4.44 % |
Sep 2023 | 2023-11-02 | $-0.37 | $-0.52 | 28.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $0 | $20.00K | -100.0 % |
Mar 2024 | 2024-05-13 | $22.00K | $10.00K | 120.0 % |
Dec 2023 | 2024-03-14 | $21.00K | $20.00K | 5.00 % |
Sep 2023 | 2023-11-02 | $43.00K | $10.00K | 330.0 % |
Allogene Therapeutics (ALLO) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.35, which hit the estimate of $-0.35.
The Actual Revenue was $0K, which missed the estimate of $20K.
Browse earnings estimates, EPS, and revenue on all stocks.